🔄 Disulfiram Cancer Research

Disulfiram, commonly known as Antabuse, is a medication traditionally used to treat alcohol use disorder by creating an aversive reaction to alcohol consumption. However, emerging cancer research has identified potential anti-cancer properties in this established pharmaceutical compound, leading scientists to investigate its repurposing as a complementary cancer therapy. This shift represents an important trend in oncology research where older medications are being re-evaluated for novel applications in fighting cancer cells.

The scientific interest in Disulfiram for cancer treatment stems from its ability to inhibit aldehyde dehydrogenase (ALDH) and copper metabolism, cellular processes that some cancer cells depend upon for survival and growth. Preclinical and early clinical studies suggest that Disulfiram may slow cancer progression and enhance the effectiveness of conventional treatments like chemotherapy. While research is still in its early to intermediate stages, the results have been promising enough to warrant continued investigation in multiple cancer types.

On this page, you'll find the latest peer-reviewed research articles examining Disulfiram's potential in cancer therapy, including mechanistic studies, laboratory findings, and early clinical trials. As with all off-label medication research, it's important to consult with your oncology team before considering any new treatment approaches. The articles below represent the most current scientific evidence available on this promising area of cancer research.